Hypertriglyceridemia in Diabetes Mellitus Type 2: How and when do we treat?
DOI:
https://doi.org/10.47196/diab.v56i3Sup.549Keywords:
hypertriglyceridemia, diabetes mellitusAbstract
Numerous epidemiological studies have highlighted the condition of high cardiovascular risk of patients with diabetes, comparable to people without diabetes who have had a major cardiovascular event previously1.
Among the factors inherent in diabetes that can explain this phenomenon, one of the most relevant is the so-called "atherogenic dyslipidemia", characterized by hypertriglyceridemia, low HDL-c and other qualitative lipoprotein changes currently well characterized, which are part of the criteria of metabolic syndrome.
References
I. Malmberg K, Yusuf S, Gerstein HC, Brown J, Zhao F, Hunt D, et al. Impact of diabetes on long-term prognosis in patients with unstable angina andnon-Q- wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 2000;102(9):1014-1019.
II. Leiter LA, Lundman P, da Silva PM, Drexel H, Jünger C, Gitt AK. Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study. Diabet Med 2011; 28:1343-1351.
III. Ganda OP, Bhatt DL, Mason RP, Miller M, Boden WE. Unmet need for adjunctive dyslipidemia therapy in hypertriglyderidemia management. J Am Coll Cardiol 2018;72(3):330-343.
IV. Tenenbaum A, et al. Hypertrigliceridemia: a too long unfairly neglected major cardiovascular risk factor. Cardiovascular Diabetology 2014;13:159.
V. Peterson B, et al. Reduction in revascularization with icosapent ethyl insights from REDUCE-IT Revascularization Analyses. Circulation 2021;143:33-44.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 on behalf of the authors. Reproduction rights: Argentine Diabetes Society
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
